279 related articles for article (PubMed ID: 21209852)
1. Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling.
Du J; Sun C; Hu Z; Yang Y; Zhu Y; Zheng D; Gu L; Lu X
PLoS One; 2010 Dec; 5(12):e15940. PubMed ID: 21209852
[TBL] [Abstract][Full Text] [Related]
2. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells.
Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY
Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181
[TBL] [Abstract][Full Text] [Related]
3. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells.
Du J; Xu R; Hu Z; Tian Y; Zhu Y; Gu L; Zhou L
PLoS One; 2011; 6(9):e25213. PubMed ID: 21980400
[TBL] [Abstract][Full Text] [Related]
4. ERK activation of p21 activated kinase-1 (Pak1) is critical for medulloblastoma cell migration.
Yuan L; Santi M; Rushing EJ; Cornelison R; MacDonald TJ
Clin Exp Metastasis; 2010 Oct; 27(7):481-91. PubMed ID: 20526801
[TBL] [Abstract][Full Text] [Related]
5. Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.
Boucharaba A; Guillet B; Menaa F; Hneino M; van Wijnen AJ; Clézardin P; Peyruchaud O
Oncol Res; 2009; 18(4):173-84. PubMed ID: 20112503
[TBL] [Abstract][Full Text] [Related]
6. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
Jang K; Kim M; Seo HS; Shin I
Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
[TBL] [Abstract][Full Text] [Related]
7. Activation of Rac1-PI3K/Akt is required for epidermal growth factor-induced PAK1 activation and cell migration in MDA-MB-231 breast cancer cells.
Yang Y; Du J; Hu Z; Liu J; Tian Y; Zhu Y; Wang L; Gu L
J Biomed Res; 2011 Jul; 25(4):237-45. PubMed ID: 23554696
[TBL] [Abstract][Full Text] [Related]
8. Anastellin, the angiostatic fibronectin peptide, is a selective inhibitor of lysophospholipid signaling.
Ambesi A; McKeown-Longo PJ
Mol Cancer Res; 2009 Feb; 7(2):255-65. PubMed ID: 19208746
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells.
Saunders JA; Rogers LC; Klomsiri C; Poole LB; Daniel LW
Free Radic Biol Med; 2010 Dec; 49(12):2058-67. PubMed ID: 20934509
[TBL] [Abstract][Full Text] [Related]
10. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: role of PI 3-kinase and ERK.
Dixon RJ; Brunskill NJ
Kidney Int; 1999 Dec; 56(6):2064-75. PubMed ID: 10594782
[TBL] [Abstract][Full Text] [Related]
12. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the ERK/HIF-1α/EMT Pathway in XCL1-Induced Migration of MDA-MB-231 and SK-BR-3 Breast Cancer Cells.
Do HTT; Cho J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374849
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
Hammer A; Diakonova M
BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
[TBL] [Abstract][Full Text] [Related]
15. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
16. P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.
Huynh N; Liu KH; Baldwin GS; He H
Biochim Biophys Acta; 2010 Sep; 1803(9):1106-13. PubMed ID: 20595063
[TBL] [Abstract][Full Text] [Related]
17. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells.
Wang Y; Chen Y; Wu M; Lan T; Wu Y; Li Y; Qian H
Oncol Lett; 2015 Jul; 10(1):502-508. PubMed ID: 26171059
[TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.
Xu KP; Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):636-43. PubMed ID: 17251460
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
20. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Jeong GO; Shin SH; Seo EJ; Kwon YW; Heo SC; Kim KH; Yoon MS; Suh DS; Kim JH
Cell Physiol Biochem; 2013; 32(2):253-63. PubMed ID: 23942151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
